Inpharma Weekly

, Volume 1349, Issue 1, pp 11–12 | Cite as

IRIS: imatinib mesylate superior in first-line treatment of CML

Meeting report
  • 5 Downloads

Keywords

Imatinib Chronic Myeloid Leukaemia Cytarabine Mesylate Imatinib Mesylate 

Copyright information

© Adis International Ltd 2002

Personalised recommendations